As an expert in the field of Market Access, Philippe Tieghem has worked for many years on a wide range of therapeutic areas, including rare diseases. He has been involved in everything from the strategy for filing applications with the authorities to the interactions and negotiations required to bring drugs to market.

​

In terms of public affairs strategies, Philippe Tieghem provides initiatives aimed at enhancing the company’s profile, differentiating it and reinforcing its credibility with stakeholders in the healthcare sector.

​ ​

With almost 40 years’ experience in the pharmaceutical industry, including six years at Chiesi, Philippe Tieghem has had the opportunity to support senior management thinking on a wide range of healthcare-related challenges, notably as CEO and BU.​